Reduction in Requirements for Allogeneic Blood Products: Pharmacologic Methods

This publication has 57 references indexed in Scilit:

• Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.
  Circulation, 1994
• 1‐deamino‐8‐D‐arginine vasopressin (DCAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass
  American Journal of Hematology, 1994
• Desmopressin and blood loss after cardiac surgery
  The Lancet, 1993
• Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin
  Journal of Cardiothoracic and Vascular Anesthesia, 1993
• The Role of Desmopressin Acetate in Patients Undergoing Coronary Artery Bypass Surgery
  Anesthesiology, 1992
• Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.
  Circulation, 1991
• Hemodynamic Consequences of Desmopressin Administration after Cardiopulmonary Bypass
  Anesthesiology, 1991
• Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressin
  Journal of the American College of Cardiology, 1987
• Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery
  New England Journal of Medicine, 1986
• Prostacyclin infusion during extracorporeal circulation for coronary bypass
  The Journal of Thoracic and Cardiovascular Surgery, 1982